GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmAust Ltd (ASX:PAA) » Definitions » Shiller PE Ratio

PharmAust (ASX:PAA) Shiller PE Ratio : (As of May. 23, 2024)


View and export this data going back to 2001. Start your Free Trial

What is PharmAust Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


PharmAust Shiller PE Ratio Historical Data

The historical data trend for PharmAust's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmAust Shiller PE Ratio Chart

PharmAust Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PharmAust Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmAust's Shiller PE Ratio

For the Biotechnology subindustry, PharmAust's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmAust's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmAust's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PharmAust's Shiller PE Ratio falls into.



PharmAust Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

PharmAust's E10 for the fiscal year that ended in Jun23 is calculated as:

For example, PharmAust's adjusted earnings per share data for the fiscal year that ended in Jun23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun23 (Change)*Current CPI (Jun23)
=-0.019/124.1700*124.1700
=-0.019

Current CPI (Jun23) = 124.1700.

PharmAust Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.017 98.352 -0.021
201506 -0.023 99.838 -0.029
201606 -0.005 100.859 -0.006
201706 -0.010 102.809 -0.012
201806 -0.016 104.945 -0.019
201906 -0.007 106.617 -0.008
202006 -0.005 106.246 -0.006
202106 -0.004 110.332 -0.005
202206 -0.005 117.112 -0.005
202306 -0.019 124.170 -0.019

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PharmAust  (ASX:PAA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


PharmAust Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of PharmAust's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmAust (ASX:PAA) Business Description

Traded in Other Exchanges
Address
1 Kyle Way, Suite 116, Claremont, Perth, WA, AUS, 6010
PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.